Unknown

Dataset Information

0

Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen.


ABSTRACT: BACKGROUNDVaccination is typically administered without regard to site of prior vaccination, but this factor may substantially affect downstream immune responses.METHODSWe assessed serological responses to initial COVID-19 vaccination in baseline seronegative adults who received second-dose boosters in the ipsilateral or contralateral arm relative to initial vaccination. We measured serum SARS-CoV-2 spike-specific Ig, receptor-binding domain-specific (RBD-specific) IgG, SARS-CoV-2 nucleocapsid-specific IgG, and neutralizing antibody titers against SARS-CoV-2.D614G (early strain) and SARS-CoV-2.B.1.1.529 (Omicron) at approximately 0.6, 8, and 14 months after boosting.RESULTSIn 947 individuals, contralateral boosting was associated with higher spike-specific serum Ig, and this effect increased over time, from a 1.1-fold to a 1.4-fold increase by 14 months (P < 0.001). A similar pattern was seen for RBD-specific IgG. Among 54 pairs matched for age, sex, and relevant time intervals, arm groups had similar antibody levels at study visit 2 (W2), but contralateral boosting resulted in significantly higher binding and neutralizing antibody titers at W3 and W4, with progressive increase over time, ranging from 1.3-fold (total Ig, P = 0.007) to 4.0-fold (pseudovirus neutralization to B.1.1.529, P < 0.001).CONCLUSIONSIn previously unexposed adults receiving an initial vaccine series with the BNT162b2 mRNA COVID-19 vaccine, contralateral boosting substantially increases antibody magnitude and breadth at times beyond 3 weeks after vaccination. This effect should be considered during arm selection in the context of multidose vaccine regimens.FUNDINGM.J. Murdock Charitable Trust, OHSU Foundation, NIH.

SUBMITTER: Fazli S 

PROVIDER: S-EPMC10940087 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen.

Fazli Sedigheh S   Thomas Archana A   Estrada Abram E AE   Ross Hiro Ap HA   Xthona Lee David D   Kazmierczak Steven S   Slifka Mark K MK   Montefiori David D   Messer William B WB   Curlin Marcel E ME  

The Journal of clinical investigation 20240116 6


BACKGROUNDVaccination is typically administered without regard to site of prior vaccination, but this factor may substantially affect downstream immune responses.METHODSWe assessed serological responses to initial COVID-19 vaccination in baseline seronegative adults who received second-dose boosters in the ipsilateral or contralateral arm relative to initial vaccination. We measured serum SARS-CoV-2 spike-specific Ig, receptor-binding domain-specific (RBD-specific) IgG, SARS-CoV-2 nucleocapsid-s  ...[more]

Similar Datasets

| S-EPMC8897957 | biostudies-literature
| S-EPMC8819635 | biostudies-literature
| S-EPMC8504644 | biostudies-literature
| S-EPMC9348753 | biostudies-literature
| S-EPMC9229433 | biostudies-literature
| S-EPMC8008753 | biostudies-literature
| S-EPMC8750654 | biostudies-literature
| S-EPMC10851277 | biostudies-literature
| S-EPMC8524478 | biostudies-literature
| S-EPMC8427169 | biostudies-literature